Suppr超能文献

原发性甲状旁腺功能亢进症患者甲状旁腺腺瘤中蛋白激酶 A Ⅰ型α调节亚基表达增加。

Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.

机构信息

Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.

出版信息

Endocr J. 2013;60(2):215-23. doi: 10.1507/endocrj.ej12-0267. Epub 2012 Nov 29.

Abstract

Protein kinase A (PKA) regulatory subunit type Iα (RIα) is a major regulatory subunit that functions as an inhibitor of PKA kinase activity. We have previously demonstrated that elevated RIα expression is associated with diffuse-to-nodular transformation of hyperplasia in parathyroid glands of renal hyperparathyroidism. The aim of the current study was to determine whether or not RIα expression is increased in adenomas of primary hyperparathyroidism (PHPT), because monoclonal proliferation has been demonstrated in both adenomas and nodular hyperplasia. Surgical specimens comprising 22 adenomas and 11 normal glands, obtained from 22 patients with PHPT, were analyzed. Western blot and immunohistochemical analyses were employed to evaluate RIα expression. PKA activities were determined in several adenomas highly expressing RIα. RIα expression was also separately evaluated in chief and oxyphilic cells using the "Allred score" system. Expression of proliferating cell nuclear antigen (PCNA), a proliferation marker, was also immunohistochemically examined. Western blot analysis revealed that 5 out of 8 adenomas highly expressed RIα, compared with normal glands. PKA activity in adenomas was significantly less than in normal glands. Immunohistochemical analysis further demonstrated high expression of RIα in 20 out of 22 adenomas. In adenomas, the greater RIα expression and more PCNA positive cells were observed in both chief and oxyphilic cells. The present study suggested that high RIα expression could contribute to monoclonal proliferation of parathyroid cells by impairing the cAMP/PKA signaling pathway.

摘要

蛋白激酶 A(PKA)调节亚基 Iα(RIα)是一种主要的调节亚基,作为 PKA 激酶活性的抑制剂发挥作用。我们之前已经证明,RIα 表达升高与肾性甲状旁腺功能亢进症甲状旁腺增生的弥漫性至结节性转化有关。本研究的目的是确定原发性甲状旁腺功能亢进症(PHPT)中的腺瘤中 RIα 表达是否增加,因为在腺瘤和结节性增生中均已证明存在单克隆增殖。分析了来自 22 名 PHPT 患者的 22 个腺瘤和 11 个正常腺体的手术标本。采用 Western blot 和免疫组织化学分析评估 RIα 表达。在几个高表达 RIα 的腺瘤中测定了 PKA 活性。还使用“Allred 评分”系统分别评估了主细胞和嗜酸性细胞中的 RIα 表达。增殖细胞核抗原(PCNA)的表达,一种增殖标志物,也通过免疫组织化学检查进行了检查。Western blot 分析显示,与正常腺体相比,8 个腺瘤中有 5 个高表达 RIα。腺瘤中的 PKA 活性明显低于正常腺体。免疫组织化学分析进一步证明了 22 个腺瘤中有 20 个高表达 RIα。在腺瘤中,无论是主细胞还是嗜酸性细胞,RIα 表达越高,PCNA 阳性细胞越多。本研究表明,高 RIα 表达可能通过损害 cAMP/PKA 信号通路,导致甲状旁腺细胞的单克隆增殖。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验